These findings are consistent with prior studies showing that elevated DKK1 levels are associated with poor outcomes in several cancers, including lung cancer, where it is believed to impact tumor progression and metastasis through its role in the Wnt signaling pathway. This evidence concerns the gene DKK1 and lung cancer.